eMed reposted this
GLP-1 care shouldn’t be hard to access and it shouldn’t be complicated. So we’re making it easy and, most of all, human. Today we’re announcing our individualized GLP-1 program, offering GLP-1 care delivered to your home. It combines GLP-1 medication with 24/7 clinical support and weekly check-ins that keep you accountable and confident – all within the comfort of your own home. Here’s how it works. 1️⃣A screening kit arrives at your doorstep. Follow the guided blood collection with a telehealth proctor, and send it back to the lab with the included FedEx label. 2️⃣A clinician reviews your lab results. If you qualify, your medication is shipped directly to you. 3️⃣You begin your journey at home backed by weekly check-ins, 24/7 care from our clinical team and ongoing health tracking. We built our program to deliver real results. Over 65,000 people have joined us in the last year, and they lost an average of 21 pounds in six months. Eight out of ten have stayed on the program. And nearly all of them improved at least one biomarker, whether cholesterol, blood sugar or liver health. For a limited time, the complete eMed program is $99 per month. That includes clinical reviews, full program access, side-effect support and a complimentary clinical-grade blood kit. If prescribed, FDA-approved medication starts at $199. eMed supports you every step of the way so you stay on track. We know that when care is personalized and guided, people stick with it and see real results. That’s what we’re building at eMed. Or as we like to say: 𝗧𝗵𝗲 𝘀𝗰𝗶𝗲𝗻𝗰𝗲 𝗼𝗳 𝘆𝗼𝘂. 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹. 𝗣𝗿𝗼𝘃𝗲𝗻. 𝗛𝘂𝗺𝗮𝗻. Wegovy ® and Ozempic ® are registered trademarks of Novo Nordisk A/S. Zepbound ® is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates. All other trademarks, registered or unregistered, are the property of their respective owners.